Anti-Human IRF8 (CT)

Anti-Human IRF8 (CT)

Product No.: I-508

[product_table name="All Top" skus="I-508"]

- -
- -
Target
IRF8
Product Type
Polyclonal Antibody
Alternate Names
Interferon Regulatory Factor 8, Interferon Consensus Sequence Binding Protein, ICSBP
Applications
WB

- -
- -
Select Product Size
- -
- -

Antibody Details

Product Details

Reactive Species
Human
Host Species
Rabbit
Immunogen
PN:I-520
Product Concentration
0.5 mg/ml
Formulation
This polyclonal antibody is formulated in phosphate buffered saline (PBS) pH 7.4 containing 0.02% sodium azide as a preservative.
Storage and Handling
This polyclonal antibody is stable for at least one week when stored at 2-8°C. For long term storage, aliquot in working volumes without diluting and store at –20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles.
Country of Origin
USA
Shipping
Next Day Ambient
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.

Description

Description

Specificity
Rabbit Anti-Human Interferon Regulatory Factor-8 (IRF8) recognizes an epitope near the C-terminus of Human, Mouse and Rat IRF8. This polyclonal antibody was purified using affinity chromatography.
Background
Interferons (IFN)s are involved in a multitude of immune interactions during viral infections and play a major role in both the induction and regulation of innate and adaptive antiviral mechanisms (1 for review). During infection, host-virus interactions signal downstream molecules such as transcription factors such as IFN regulatory factor-3 (IRF3) which can act to stimulate transcription of IFN-α/β genes. Unlike IRF3, IRF8 appears to act as a negative regulator of IFN-induced genes in most cases,2,3 but IRF8 mediates activation of NF-κB by the toll-like receptor 9 (TLR9) after stimulation by unmethylated CpG DNA in dendritic cells.4 Finally, it has been shown that IRF8 decreases bcl-2 expression and thus may play a role in chronic myelogenous leukemia.
PubMed

References & Citations

1. Malmgaard, L. (2004) J. Interferon & Cyto. Res. 24:439 2. Weisz, A. et al. (1992) J. Biol. Chem. 267:25589 3. Nelson, N. et al. (1993) Mol. Cell. Biol. 13:588 4. Tsujimura, H. et al. (2004) J. Immunol. 172:6820
General Western Blot Protocol

Certificate of Analysis

- -
- -
Prod No.
Description
I-508
I-520
Disclaimer AlertProducts are for research use only. Not for use in diagnostic or therapeutic procedures.